Vincent Medical, a leading name in the medical device industry, is headquartered in Hong Kong and operates extensively across Asia and beyond. Founded in 2001, the company has established itself as a pioneer in the development of innovative respiratory and anaesthesia solutions, catering to the needs of healthcare professionals worldwide. Specialising in high-quality medical equipment, Vincent Medical offers a range of products, including advanced nebulisers and oxygen therapy devices, known for their reliability and user-friendly design. The company’s commitment to research and development has positioned it as a trusted partner in the healthcare sector, with notable achievements in enhancing patient care and safety. With a strong market presence and a reputation for excellence, Vincent Medical continues to lead the way in medical technology, striving to improve health outcomes globally.
How does Vincent Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Vincent Medical's score of 35 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Vincent Medical reported total carbon emissions of approximately 5,651,160 kg CO2e, a decrease from 7,210,800 kg CO2e in 2023. The emissions breakdown for 2024 includes Scope 1 emissions of about 62,850 kg CO2e, Scope 2 emissions of approximately 5,353,760 kg CO2e, and Scope 3 emissions of about 92,150 kg CO2e. This indicates a significant reduction in total emissions, reflecting the company's commitment to improving its environmental performance. Vincent Medical's emissions data is cascaded from its parent company, Vincent Medical Holdings Limited, which provides a comprehensive overview of the organisation's carbon footprint. The company has not set specific reduction targets under the Science Based Targets initiative (SBTi) or other climate pledges, indicating a potential area for future commitment. Historically, emissions have shown fluctuations, with total emissions peaking at approximately 12,315,000 kg CO2e in 2022. The company has disclosed emissions across all three scopes, demonstrating transparency in its reporting practices. Overall, Vincent Medical is actively working towards reducing its carbon emissions, although further commitments and targets could enhance its climate strategy.
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 14,000 | 00,000 | 00,000 | 00,000 | 00,000 | 00,000 | 00,000 |
| Scope 2 | 10,855,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 231,000 | 000,000 | 0,000 | 0,000 | 00,000 | 00,000 | 00,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Vincent Medical has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

